The phrase "adverse event data" is correct and usable in written English.
It can be used in contexts related to healthcare, clinical trials, or research where negative occurrences or side effects are being reported or analyzed.
Example: "The researchers compiled the adverse event data to assess the safety of the new medication."
Alternatives: "negative incident data" or "harmful event information".
The government is also well-positioned to coordinate the private surgical research marketplace through activities such as the aggregation of country-level adverse event data and the setting of standards for medical terminology and guidelines for study protocols.
One patient was excluded due to missing adverse event data.
MATERIALS AND METHODS:Adverse event data were available for 615 of 633 enrolled patients.
Adverse event data were derived from the CLASS, MEDAL, TARGET, EDGE and CONDOR studies [6, 12 16, 19, 20].
Data from five large randomized controlled trials that report GI and CV events associated with NSAID use in predominantly OA patients were used to obtain adverse event data for this analysis.
Adverse event data were pooled from five randomized controlled trials rather than real-life situations; however, these were large studies conducted in multiple centres across several countries, and may, therefore, be considered to reflect real-life incidence of adverse events.
In order to improve the accuracy and efficiency of collecting and grading adverse event data, the NCI has established the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) measurement system [4, 5, 6, 7].
When contacted for comment, Courtney Mallon, the deputy director of product communications for Bayer, said that the company takes "all adverse events seriously and continuously collect and analyze all adverse event data we receive for our products.
Primary outcome measures were laboratory safety and adverse event data.
[15] This study, however, contains numerous features intended to minimize the limitations of adverse event data from postmarketing surveillance.
Other outcomes included measures of parasite specific immune responses induced by either vaccine; and safety, assessed by collection of adverse event data.
